Lenalidomide versus investigator's choice in relapsed or refractory mantle cell lymphoma (MCL-002; SPRINT): a phase 2, randomised, multicentre trial
scientific article
Author/s
author: Lorenz Trümper, Sergey Voloshin, David Belada, Boris Afanasyev, Wojciech Jurczak, Jan Walewski, Marek Trněný, Noel Jean Milpied, John Radford, Kazimierz Kuliczkowski, Simon A Rule, Thierry Lamy, Franck Morschhauser, Julia Alexeeva, Agnieszka Giza, Tsvetan Biyukov, Meera Patturajan, Marie-Laure Casadebaig Bravo
Work details
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.